Michael Polark
Stock Analyst at Wolfe Research
(3.83)
# 1,967
Out of 4,835 analysts
173
Total ratings
50.8%
Success rate
6.4%
Average return
Main Sectors:
Stocks Rated by Michael Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Upgraded: Buy | $130 | $103.36 | +25.77% | 6 | Aug 13, 2026 | |
| A Agilent Technologies | Initiated Coverage: Hold | $135 | $143.12 | -5.67% | 1 | Jun 1, 2026 | |
| AVTR Avantor | Rated: Sell | $7 | $14.88 | -52.96% | 1 | Jun 1, 2026 | |
| BRKR Bruker | Downgraded: Hold | n/a | $53.56 | - | 1 | Jun 1, 2026 | |
| CAI Caris Life Sciences | Downgraded: Hold | n/a | $24.04 | - | 1 | Jun 1, 2026 | |
| DHR Danaher | Downgraded: Hold | n/a | $200.53 | - | 1 | Jun 1, 2026 | |
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,180 | $1,280.58 | -7.85% | 1 | Jun 1, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $145 | $164.68 | -11.95% | 1 | Jun 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | n/a | $120.94 | - | 1 | Jun 1, 2026 | |
| STVN Stevanato Group | Initiated Coverage: Buy | $21 | $20.95 | +0.24% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $535 | $603.18 | -11.30% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $401.64 | +5.82% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $375 | $344.25 | +8.93% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $43.10 | - | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $86.77 | +6.03% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $68.12 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $32.39 | +45.11% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $91.62 | n/a | 6 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $13.87 | n/a | 11 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $18.26 | n/a | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $270 | $212.45 | n/a | 17 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $16.59 | n/a | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $78.18 | n/a | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $350 | $134.68 | n/a | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $23.57 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $180 | $219.58 | n/a | 14 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $405 | $270.01 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $92.44 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $115 | $112.88 | n/a | 19 | Jun 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.89 | n/a | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $140 | $84.51 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $132.00 | n/a | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $18.31 | n/a | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $315 | $360.46 | n/a | 9 | Apr 5, 2022 |
Abbott Laboratories
Aug 13, 2026
Upgraded: Buy
Price Target: $130
Current: $103.36
Upside: +25.77%
Agilent Technologies
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $135
Current: $143.12
Upside: -5.67%
Avantor
Jun 1, 2026
Rated: Sell
Price Target: $7
Current: $14.88
Upside: -52.96%
Bruker
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $53.56
Upside: -
Caris Life Sciences
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $24.04
Upside: -
Danaher
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $200.53
Upside: -
Mettler-Toledo International
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $1,180
Current: $1,280.58
Upside: -7.85%
Repligen
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $164.68
Upside: -11.95%
Revvity
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $120.94
Upside: -
Stevanato Group
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $20.95
Upside: +0.24%
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $535
Current: $603.18
Upside: -11.30%
Jun 1, 2026
Reiterated: Buy
Price Target: $425
Current: $401.64
Upside: +5.82%
Jun 1, 2026
Rated: Buy
Price Target: $375
Current: $344.25
Upside: +8.93%
May 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.10
Upside: -
Apr 1, 2026
Upgraded: Buy
Price Target: $92
Current: $86.77
Upside: +6.03%
Feb 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $68.12
Upside: -
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $32.39
Upside: +45.11%
Aug 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $91.62
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: $14 → $13
Current: $13.87
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $19 → $17
Current: $18.26
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $245 → $270
Current: $212.45
Upside: n/a
May 29, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $16.59
Upside: n/a
May 19, 2025
Upgraded: Buy
Price Target: $60
Current: $78.18
Upside: n/a
May 12, 2025
Upgraded: Buy
Price Target: $350
Current: $134.68
Upside: n/a
Mar 31, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $23.57
Upside: n/a
Sep 17, 2024
Downgraded: Sell
Price Target: $180
Current: $219.58
Upside: n/a
Sep 9, 2024
Initiated Coverage: Buy
Price Target: $405
Current: $270.01
Upside: n/a
Sep 9, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $92.44
Upside: n/a
Jun 19, 2024
Upgraded: Buy
Price Target: $115
Current: $112.88
Upside: n/a
Oct 19, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $4.89
Upside: n/a
Jul 28, 2023
Reiterated: Buy
Price Target: $121 → $140
Current: $84.51
Upside: n/a
Apr 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $132.00
Upside: n/a
Jan 26, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $18.31
Upside: n/a
Apr 5, 2022
Initiated Coverage: Hold
Price Target: $315
Current: $360.46
Upside: n/a